Hedge fund group is seeking to break up Kleinwort Benson for poor performance and 'erratic' management strategy.

AstraZeneca acquires Omthera's fish oil derived pharmaceutical line. In an announcement, AstraZeneca would be acquiring Omthera Pharmaceuticals for the price of US$443 million to boost its cardiovascular drug business.

Azul Linhas Aereas is planning a share sale to raise funds to purchase new planes. Azul Linhas Aereas, the third largest airline of Brazil, is planning to raise 1.

Valeant purchases Bausch & Lomb to create business unit that can generate US$3.5 billion in net revenue.

EFES is affected by law passed by the Turkish government. The largest beermaker in the Middle East is being buffetted in the world's credit markets at the same time Turkish Prime Minister Recep Tayyip Erdogan has been clamping down on sales of alcohol and its attendant advertising.

The Brazilian National Bank would be funding the railroad connection between Ethiopia and South Sudan.

Hikma Pharmaceuticals is prepared to make many acquisitions with the funds it has set aside. Hikma Pharmaceuticals, based out of London, says it has set aside US$600 million to pay for acquisitions it would be making in the Middle East and Africa.

According to its CEO, Majid al Futtaim is earmarking between US$600 million and US$1 billion for acquisitions this year.

Singapore Press would be undertaking the REIT IPO of two malls in its portfolio. Singapore Press Holdings Ltd had announced last Monday that it is planning to list two shopping malls worth Sing$3.

Fiera Capital is pursuing to double its assets through acquisitions of US firms. The Canadian money manager Fiera Capital Corp is planning to increase its assets to more than double the current value of Can$150 billion or US$145 billion through the addition of smaller US firms.